PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Eurobio Scientific Société anonyme (ALERS.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINFR0013240934
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap€247.54M
EPS (TTM)€0.43
PE Ratio57.33
Total Revenue (TTM)€70.85M
Gross Profit (TTM)€29.65M
EBITDA (TTM)€13.66M
Year Range€12.20 - €24.75
Target Price€30.00

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Eurobio Scientific Société anonyme

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Eurobio Scientific Société anonyme, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%50.00%AprilMayJuneJulyAugust
49.24%
9.29%
ALERS.PA (Eurobio Scientific Société anonyme)
Benchmark (^GSPC)

S&P 500

Returns By Period

Eurobio Scientific Société anonyme had a return of 49.76% year-to-date (YTD) and 57.01% in the last 12 months. Over the past 10 years, Eurobio Scientific Société anonyme had an annualized return of 6.88%, while the S&P 500 had an annualized return of 10.95%, indicating that Eurobio Scientific Société anonyme did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date49.76%18.42%
1 month35.44%2.28%
6 months50.30%9.95%
1 year57.01%25.31%
5 years (annualized)47.48%14.08%
10 years (annualized)6.88%10.95%

Monthly Returns

The table below presents the monthly returns of ALERS.PA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20242.67%-1.78%-3.01%-10.56%1.39%-5.34%31.69%49.76%
2023-13.06%1.98%-12.19%2.84%4.29%-18.24%5.61%6.95%-8.28%8.89%4.59%0.37%-19.16%
2022-21.25%-4.53%14.92%-21.50%12.27%3.90%-7.98%-6.12%-12.93%4.99%14.68%5.55%-24.37%
202118.58%-5.97%6.35%-0.40%-3.00%-7.00%-5.32%10.18%-8.39%3.48%16.69%29.17%58.82%
20203.62%46.09%39.15%18.93%-25.79%-10.09%39.03%8.26%3.81%29.80%-4.72%11.88%261.41%
201920.07%-11.96%-1.85%2.52%2.45%1.50%7.67%-6.58%7.04%16.44%-3.06%13.83%53.02%
2018-1.06%-4.28%-3.47%6.26%6.87%-1.33%5.27%-5.40%-19.00%-5.38%3.12%-19.45%-35.06%
2017-17.24%8.33%3.85%-7.41%4.00%26.92%-9.09%-3.33%-4.66%-7.78%-8.82%1.51%-18.62%
2016-10.42%-2.32%0.00%0.00%0.00%-11.91%8.11%-2.50%-12.82%-11.77%6.67%-3.13%-35.42%
20151.70%1.67%-3.28%-3.39%3.51%-5.08%41.07%-24.05%-20.00%4.17%0.00%-4.00%-18.64%
201436.36%7.78%-5.15%-8.70%-2.38%-9.76%-5.41%-1.43%-7.25%-14.06%23.64%-13.24%-10.61%
20136.67%3.12%-8.08%-13.19%-6.33%-8.11%-1.47%5.97%-1.41%-8.57%-0.00%3.12%-26.67%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of ALERS.PA is 82, placing it in the top 18% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ALERS.PA is 8282
ALERS.PA (Eurobio Scientific Société anonyme)
The Sharpe Ratio Rank of ALERS.PA is 7979Sharpe Ratio Rank
The Sortino Ratio Rank of ALERS.PA is 9393Sortino Ratio Rank
The Omega Ratio Rank of ALERS.PA is 8989Omega Ratio Rank
The Calmar Ratio Rank of ALERS.PA is 7070Calmar Ratio Rank
The Martin Ratio Rank of ALERS.PA is 8080Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Eurobio Scientific Société anonyme (ALERS.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ALERS.PA
Sharpe ratio
The chart of Sharpe ratio for ALERS.PA, currently valued at 1.09, compared to the broader market-4.00-2.000.002.001.09
Sortino ratio
The chart of Sortino ratio for ALERS.PA, currently valued at 2.99, compared to the broader market-6.00-4.00-2.000.002.004.002.99
Omega ratio
The chart of Omega ratio for ALERS.PA, currently valued at 1.36, compared to the broader market0.501.001.501.36
Calmar ratio
The chart of Calmar ratio for ALERS.PA, currently valued at 0.55, compared to the broader market0.001.002.003.004.005.000.55
Martin ratio
The chart of Martin ratio for ALERS.PA, currently valued at 4.78, compared to the broader market-5.000.005.0010.0015.0020.004.78
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.02, compared to the broader market-4.00-2.000.002.002.02
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-6.00-4.00-2.000.002.004.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.501.001.501.36
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.77, compared to the broader market0.001.002.003.004.005.001.77
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.33, compared to the broader market-5.000.005.0010.0015.0020.009.33

Sharpe Ratio

The current Eurobio Scientific Société anonyme Sharpe ratio is 1.09. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Eurobio Scientific Société anonyme with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AprilMayJuneJulyAugust
1.09
1.94
ALERS.PA (Eurobio Scientific Société anonyme)
Benchmark (^GSPC)

Dividends

Dividend History


Eurobio Scientific Société anonyme doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AprilMayJuneJulyAugust
-94.34%
-1.73%
ALERS.PA (Eurobio Scientific Société anonyme)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Eurobio Scientific Société anonyme. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Eurobio Scientific Société anonyme was 99.32%, occurring on Dec 24, 2018. The portfolio has not yet recovered.

The current Eurobio Scientific Société anonyme drawdown is 94.34%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.32%Apr 6, 20063254Dec 24, 2018
-40%Dec 27, 200529Feb 3, 200618Mar 1, 200647
-29.72%Nov 23, 20056Nov 30, 200514Dec 20, 200520
-25.49%Mar 3, 20065Mar 9, 200614Mar 29, 200619
-1.14%Mar 31, 20061Mar 31, 20061Apr 3, 20062

Volatility

Volatility Chart

The current Eurobio Scientific Société anonyme volatility is 0.88%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%AprilMayJuneJulyAugust
0.88%
6.16%
ALERS.PA (Eurobio Scientific Société anonyme)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Eurobio Scientific Société anonyme over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Eurobio Scientific Société anonyme.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items